J Clin Pharmacol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (14)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lotrich, F. E.
Right arrow Articles by Pollock, B. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lotrich, F. E.
Right arrow Articles by Pollock, B. G.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

THERAPEUTIC REVIEW

Aging and Clinical Pharmacology: Implications for Antidepressants

Francis E. Lotrich, MD, PhD and Bruce G. Pollock, MD, PhD

From the Department of Psychiatry, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania (Dr Lotrich) and Rotman Research Institute, Baycrest Centre for Geriatric Care, University of Toronto, Canada (Dr Pollock).

The elderly frequently have changes in pharmacokinetics, sensitivity to medications, homeostatic reserve (ability to tolerate physiological challenges), exposure to multiple medications, and adherence. All of these age-associated factors can potentially influence total exposure to medication, adverse effects, and subsequent treatment outcome. Most clinical trials are performed with healthy, younger adults. Extrapolating the results of these trials to the elderly may be inappropriate, particularly for the antidepressant treatment of depression. The authors review these age-associated differences and discuss their implications for antidepressant use in older adults.


Key Words: Elderlypharmacokineticsantidepressants

Address for reprints: Francis E. Lotrich, Western Psychiatric Institute and Clinic, University of Pittsburgh Medical Center, 3811 Ohara Street, Pittsburgh, PA 15213; e-mail: lotrichfe{at}upmc.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Am. J. PsychiatryHome page
M. A. Dew, E. M. Whyte, E. J. Lenze, P. R. Houck, B. H. Mulsant, B. G. Pollock, J. A. Stack, S. Bensasi, and C. F. Reynolds III
Recovery From Major Depression in Older Adults Receiving Augmentation of Antidepressant Pharmacotherapy
Am J Psychiatry, June 1, 2007; 164(6): 892 - 899.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American College of Clinical Pharmacology